Five opioid manufacturers, including OxyContin maker Purdue Pharma LP, have paid more than US$10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a US Senate report said on Monday.
The report, released by Senator Claire McCaskill, said groups who received the donations aligned themselves with industry goals and might have played a role in an epidemic that in 2016 led to 42,000 opioid overdose deaths.
The report released by McCaskill, the US Senate Homeland Security and Governmental Affairs Committee’s ranking Democrat, said the groups issued guidance promoting opioids for chronic pain and lobbied against laws to curb their use.
“These financial relationships were insidious, lacked transparency and are one of many factors that have resulted in arguably the most deadly drug epidemic in American history,” McCaskill said in a statement.
Purdue Pharma, which on Saturday announced it would stop promoting opioids to doctors, was the biggest donor, giving US$4.15 million to 12 groups from 2012 to last year, the report said.
The groups include patient advocacy organizations and medical professional societies, the report said.
One recipient was the Academy of Integrative Pain Management (AIPM), which partnered with another group to lobby state legislatures on opioid-related issues and fight efforts to restrict opioid prescribing, it said.
Purdue said in a statement that it supported organizations interested in helping patients receive appropriate care. AIPM executive director Bob Twillman said that financial contributions had not influenced its positions.
The report said Insys Therapeutics Inc, which markets the fentanyl-based cancer pain drug Subsys, gave US$3.15 million to the US Pain Foundation and others, ranking No. 2 in donations to the 14 groups examined.
Federal prosecutors have accused several former Insys executives and employees, including billionaire Insys founder John Kapoor, of engaging in a scheme to pay kickbacks to doctors to prescribe Subsys. Kapoor has pleaded not guilty.
The US Pain Foundation said the US$2.5 million Insys donated last year was for a fund to help cancer patients pay for pain drugs, and that the money did not influence its values. Insys said it strives to follow regulations.
The report said the groups also received US$1.07 million from Depomed Inc, US$465,142 from Johnson & Johnson and US$20,250 from Mylan NV.
Doctors affiliated with the organizations received US$1.6 million, the report said.
Depomed said its contributions amounted to on average just about US$20,000 a year for nine groups and said it believed it acted responsibly in marketing its drugs.
Johnson & Johnson said it co-operated with McCaskill, while Mylan emphasized its small opioid market share.
A coronavirus-free tropical island nestled in the northern Pacific might seem the perfect place to ride out a pandemic, but residents on Palau said that life right now is far from idyllic. The microstate of 18,000 people is among a dwindling number of places on Earth that still report zero cases of COVID-19 as figures mount daily elsewhere. The disparate group also includes Samoa, Turkmenistan, North Korea and bases on the frozen continent of Antarctica. A dot in the ocean hundreds of kilometers from its nearest neighbors, Palau is surrounded by the vast Pacific Ocean, which has acted as a buffer against the
Dutch scientists have found the coronavirus in a city’s wastewater before COVID-19 cases were reported, demonstrating a novel early warning system for the disease. SARS-CoV-2 — the virus that causes COVID-19 — is often excreted in an infected person’s stool. Although it is unlikely that sewage will become an important route of transmission, the pathogen’s increasing circulation in communities would increase the amount of it flowing into sewer systems, Gertjan Medema and colleagues at the KWR Water Research Institute in Nieuwegein said on Monday. They detected genetic material from the coronavirus at a wastewater treatment plant in Amersfoort on March 5, before
TRUE TOLL? Some Chinese are skeptical about official data, particularly given the overwhelmed medical system and initial attempts to cover up the outbreak The long lines and stacks of urns greeting family members of the dead at funeral homes in Wuhan, China, are spurring questions about the true scale of casualties at the epicenter of the COVID-19 outbreak, renewing pressure on a Chinese government struggling to control its containment narrative. The families of those who succumbed to the coronavirus in the city, where the disease first emerged, were allowed to pick up their cremated ashes at eight funeral homes last week. As they did, photographs circulated on Chinese social media of thousands of urns being ferried in. Outside one funeral home, trucks shipped in about 2,500
KEEN INTEREST: India is trying to procure medical gear from domestic producers and abroad, and China has emerged as a possible supplier as its factories reopen India is to buy ventilators and masks from China to help it deal with COVID-19, a government official said yesterday, even though some countries in Europe had complained about the quality of the equipment. India has recorded 1,251 cases of the coronavirus, with 32 deaths, but health experts said the country of 1.3 billion people could see a major surge in cases that could overwhelm its weak public health system. Indian Prime Minister Narendra Modi’s government said that it was trying to procure medical gear, including masks and body coveralls, both from domestic firms and from countries such as South Korea and